Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The complete resection of liver metastasis LM is usually recommended in patients with grade 1-2 NET. The exact benefit of resection of peritoneal metastasis PM is unknown.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Benhaim L
Authors: Benhaim L, Faron M, Gelli M, Boige V, Malka D,
Keywords: Liver metastasis, peritoneal metastasis, surgery,
Introduction: Microsatellite instability (MSI) has been reported to occur in a significant proportion of neuroendocrine carcinoma (NEC) and mixed adenoneuroendocrine carcinomas (MANEC) (11 out of 89 cases, Sahnane et al, ERC 2015). It might be predictive of response to immunotherapy.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Hadoux J
Authors: Hadoux J, Malka D, Berdeloux A, Planchard D, Boige V,
Keywords: Neuroendocrine carcinoma, mismatch repair, microsatellite instability,
Introduction: Everolimus is an oral inhibitor of mammalian target of rapamycin(mTOR) with antitumor activity in patients(pts) with pancreatic neuroendocrine tumor(pNET)s
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Del Prete M
Authors: Del Prete M, Malka L, Borget I, Berdelou A, Boige V,
Keywords: Pancreatic Neuroendocrine Tumor, Everolimus, Safety,
Introduction: At least 9 therapeutic options are now available for unresectable WDpNET patients. Whether all lines can be administrated before tumor or toxic-related deaths is currently unknown.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Berdelou A, Malka D, Leboulleux S, Boige V, Chougnet C,
Keywords: pNets,
Introduction: Cisplatin/etoposide regimen is the recommended first line treatment for poorly differentiated grade 3 neuroendocrine carcinoma (G3-NEC). There is no standard second line.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author:
Authors: Hadoux J, Guigay J, Malka D, Planchard D, Boige V,
Keywords: neuroendocrine carcinoma, grade 3, oxaliplatin,